Guinness Asset Management is a London-based specialist fund management company established in 2003 that manages over £3bn for institutional and retail investors.
Edward serves as chief executive at Guinness Global Investors and Guinness Atkinson Asset Management, following earlier analytical and corporate finance roles at Tiedemann Investment Group and HSBC.
Malcolm brings venture capital and investment management experience from roles at Guinness Ventures and The Carbon Trust. He previously founded Britenight Solar Lighting and now serves as Director and Chief Investment Officer at Guinness Ventures.
Ashley manages funds and heads origination at Guinness Ventures and Guinness Asset Management. Alongside this, they hold several non-executive director roles.
The financing round was led by Kairos HQ alongside Schroders Capital and other backers to expand at-home patient care capacity.
"Since Cera’s launch in November 2016 the company has scaled at an unprecedented rate for the sector, benefiting countless lives, and proving the need for technology-powered improvement in healthcare. Receiving such significant financial backing during this period of global economic volatility, is testament to the strength of Cera’s business model, our innovation, and our commitment to revolutionising healthcare. We’re now in pole position to be able to use our unique technology to expand what we do for patients across the world who are in need of care, while relieving pressures on public services."
Guinness Asset Management led the Series A round to support team expansion and kitchen network growth.
"We are proud to take investment from such a forward-thinking, collaborative fund as Guinness. Our purpose is to be a voice for the independents, championing change and empowerment, and it’s great to see our new partners entirely bought into that mission."
The Series A round was led by Maven VC and Guinness Asset Management to support post-pandemic healthcare recovery.
"As we continue to accelerate and invest in the ethical use of clinical research data to advance new medicines for patient care, this funding gives us the capital needed to carry out our immediate plans while delivering AI solutions which will help futureproof our NHS."
